Trinity Biotech Plc (Trinity Biotech) is a medical equipment company, which develops, acquires, manufactures, and distributes diagnostic systems for clinical laboratory and point-of-care market sectors. The company’s product portfolio encompasses diagnostic tests and instruments that are used to detect hemoglobin A1c for diabetes monitoring and diagnosis, infectious diseases, autoimmune, sexually transmitted diseases, and liver and intestine disorders. It also offers raw materials to research and life sciences industries. Trinity Biotech markets its products through direct sales in the US, Brazil, Germany, France and the UK; and through a network of distributors and strategic partnerships in other countries. The company has manufacturing facilities in the US, Brazil, and Ireland. Trinity Biotech is headquartered in Wicklow, Ireland.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Trinity Biotech Plc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Trinity Biotech Plc Company Overview
- Trinity Biotech Plc Company Snapshot
- Trinity Biotech Plc Pipeline Products and Ongoing Clinical Trials Overview
- Trinity Biotech Plc - Pipeline Analysis Overview
- Business Description
- Trinity Biotech Plc - Key Facts
- Trinity Biotech Plc - Major Products and Services
- Trinity Biotech Plc Pipeline Products by Development Stage
- Trinity Biotech Plc Pipeline Products Overview
- 10-Minute COVID-19 Antigen Test
- 10-Minute COVID-19 Antigen Test Product Overview
- COVID-19 Rapid Antibody Test
- COVID-19 Rapid Antibody Test Product Overview
- COVID-19 Rapid Antigen Test
- COVID-19 Rapid Antigen Test Product Overview
- D-dimer Test
- D-dimer Test Product Overview
- Diagnostic Assay - Dengue
- Diagnostic Assay - Dengue Product Overview
- HIV Self-Test Kit
- HIV Self-Test Kit Product Overview
- Lateral Flow Test - Infectious Disease
- Lateral Flow Test - Infectious Disease Product Overview
- Long COVID Autoimmune Lab Test
- Long COVID Autoimmune Lab Test Product Overview
- Meritas Point of Care Analyzer
- Meritas Point of Care Analyzer Product Overview
- Multiplex Cardiac Panel
- Multiplex Cardiac Panel Product Overview
- Premier Resolution
- Premier Resolution Product Overview
- ScopeSmart
- ScopeSmart Product Overview
- Screening Test - Malaria
- Screening Test - Malaria Product Overview
- Tri-stat 2 Analyzer
- Tri-stat 2 Analyzer Product Overview
- TrinScreen HIV
- TrinScreen HIV Product Overview
- Uni-Gold C. Difficile Toxin A/B Control Kit
- Uni-Gold C. Difficile Toxin A/B Control Kit Product Overview
- Uni-Gold C. Difficile GDH Control Kit
- Uni-Gold C. Difficile GDH Control Kit Product Overview
- Uni-Gold Chlamydia Test
- Uni-Gold Chlamydia Test Product Overview
- Uni-Gold Legionella Urinary Antigen PLUS Test
- Uni-Gold Legionella Urinary Antigen PLUS Test Product Overview
- Uni-Gold S. Pneumoniae Test
- Uni-Gold S. Pneumoniae Test Product Overview
- Uni-Gold Syphilis-Combo
- Uni-Gold Syphilis-Combo Product Overview
- Uni-Gold Tuberculosis Test
- Uni-Gold Tuberculosis Test Product Overview
- Trinity Biotech Plc - Key Competitors
- Trinity Biotech Plc - Key Employees
- Trinity Biotech Plc - Key Employee Biographies
- Trinity Biotech Plc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Trinity Biotech Plc, Recent Developments
- Nov 03, 2022: Trinity Biotech Announces Quarter 2 2022 Financial Results And Preliminary Q3 2022 Revenue Guidance
- Dec 15, 2021: Trinity Biotech Announces Q3 2021 Results, the Entry Into a $81,250,000 Loan Facility to Refinance the Company’s Exchangeable Senior Notes and Agreements To Repurchase Outstanding Exchangeable Senior Notes
- Jul 16, 2021: Trinity Biotech Provides a Business Development Update For Q2 2021
- May 25, 2021: Trinity Biotech Announces Results for Q1 2021
- Mar 25, 2021: Trinity Biotech Announces Quarter 4 and Fiscal Year 2020 Financial Results
- Nov 17, 2020: Trinity Biotech plc to Announce Third Quarter 2020 Financial Results
- Oct 16, 2019: Trinity Biotech announces results for Q3, 2019
- Aug 20, 2019: Trinity Biotech announces results for Q2, 2019
- May 07, 2019: Trinity Biotech announces results for Q1, 2019
- Mar 07, 2019: Trinity Biotech announces quarter 4 and fiscal year 2018 financial results
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Trinity Biotech Plc Pipeline Products and Ongoing Clinical Trials Overview
- Trinity Biotech Plc Pipeline Products by Equipment Type
- Trinity Biotech Plc Pipeline Products by Indication
- Trinity Biotech Plc, Key Facts
- Trinity Biotech Plc, Major Products and Services
- Trinity Biotech Plc Number of Pipeline Products by Development Stage
- Trinity Biotech Plc Pipeline Products Summary by Development Stage
- 10-Minute COVID-19 Antigen Test - Product Status
- 10-Minute COVID-19 Antigen Test - Product Description
- COVID-19 Rapid Antibody Test - Product Status
- COVID-19 Rapid Antibody Test - Product Description
- COVID-19 Rapid Antigen Test - Product Status
- COVID-19 Rapid Antigen Test - Product Description
- D-dimer Test - Product Status
- D-dimer Test - Product Description
- Diagnostic Assay - Dengue - Product Status
- Diagnostic Assay - Dengue - Product Description
- HIV Self-Test Kit - Product Status
- HIV Self-Test Kit - Product Description
- Lateral Flow Test - Infectious Disease - Product Status
- Lateral Flow Test - Infectious Disease - Product Description
- Long COVID Autoimmune Lab Test - Product Status
- Long COVID Autoimmune Lab Test - Product Description
- Meritas Point of Care Analyzer - Product Status
- Meritas Point of Care Analyzer - Product Description
- Multiplex Cardiac Panel - Product Status
- Multiplex Cardiac Panel - Product Description
- Premier Resolution - Product Status
- Premier Resolution - Product Description
- ScopeSmart - Product Status
- ScopeSmart - Product Description
- Screening Test - Malaria - Product Status
- Screening Test - Malaria - Product Description
- Tri-stat 2 Analyzer - Product Status
- Tri-stat 2 Analyzer - Product Description
- TrinScreen HIV - Product Status
- TrinScreen HIV - Product Description
- Uni-Gold C. Difficile Toxin A/B Control Kit - Product Status
- Uni-Gold C. Difficile Toxin A/B Control Kit - Product Description
- Uni-Gold C. Difficile GDH Control Kit - Product Status
- Uni-Gold C. Difficile GDH Control Kit - Product Description
- Uni-Gold Chlamydia Test - Product Status
- Uni-Gold Chlamydia Test - Product Description
- Uni-Gold Legionella Urinary Antigen PLUS Test - Product Status
- Uni-Gold Legionella Urinary Antigen PLUS Test - Product Description
- Uni-Gold S. Pneumoniae Test - Product Status
- Uni-Gold S. Pneumoniae Test - Product Description
- Uni-Gold Syphilis-Combo - Product Status
- Uni-Gold Syphilis-Combo - Product Description
- Uni-Gold Tuberculosis Test - Product Status
- Uni-Gold Tuberculosis Test - Product Description
- Trinity Biotech Plc, Key Employees
- Trinity Biotech Plc, Key Employee Biographies
- Trinity Biotech Plc, Subsidiaries
- Glossary
- Trinity Biotech Plc Pipeline Products by Equipment Type
- Trinity Biotech Plc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- DiaSorin Inc
- Abbott Diagnostics
- Bio-Rad Laboratories Inc
- Thermo Fisher Scientific Inc
- Siemens Healthineers AG
- Becton Dickinson and Co
- Johnson & Johnson
- Roche Diagnostics
